Home
Home About Us Our Team Our Portfolio Press Releases Contact Us
About Us
 
 
 
 
 

NxStage® and Dirinco Sign Distribution Agreement For System One™ in the Netherlands
March 2, 2010


Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome
February 17, 2010


Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo® Formulation
February 9, 2010


Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX™ for the Treatment of Dupuytren's Contracture
February 3, 2010


NxStage® and Nordic Medcom Sign Distribution Agreement for the System One™
February 3, 2010


Pearl Therapeutics Raises $15 Million to Advance PT003, LAMA/LABA Combination Bronchodilator for COPD, into Phase 2b Study
February 1, 2010


World Heart Corp. Completes $7.3 Million Private Placement
January 26, 2010


Prometheus Acquires Exclusive Rights to PROLEUKIN® (aldesleukin) in the U.S.
January 26, 2010


Labcyte Expands Acoustic Dispensing and Launches Into New Markets
January 26, 2010


Affymax Completes Treatment and Last Patient Follow-up in Phase 3 Program for Investigational Drug, Hematide™, to Treat Anemia in Chronic Renal Failure
January 25, 2010


Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's Contracture
January 21, 2010


WorldHeart Announces First U.S. Implant of Levacor™ VAD Implant at INTEGRIS in Oklahoma City
January 19, 2010


ISTA Pharmaceuticals announces trial results for topical Xibrom 0.09%
January 11, 2010


WorldHeart Receives Unconditional BTT Study Approval From FDA for Levacor™ VAD
January 8, 2010


Tolerx Completes Enrollment in DEFEND-1, a Phase 3 Type 1 Diabetes Study with Otelixizumab
January 7, 2010


Sopherion Therapeutics Receives FDA Fast Track Designation for Myocet in Metastatic Breast Cancer
January 7, 2010


Prometheus Completes $260 Million Financing
January 7, 2010


Pearl Therapeutics Announces Positive Results from Phase 2a Trial of Glycopyrrolate Inhalation Aerosol in Chronic Obstructive Pulmonary Disease
January 6, 2010


Pearl Therapeutics Announces Positive Results from Phase 2a Trial of Formoterol Inhalation Aerosol in Chronic Obstructive Pulmonary Disease
January 4, 2010


Newly Formed Durata Therapeutics Acquires Pfizer’s Vicuron Subsidiary
December 21, 2009


ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay™
December 17, 2009


Auxilium Announces Top Line Phase IIb XIAFLEX™ Peyronie's Results
December 16, 2009


Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
December 16, 2009


Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo®
December 14, 2009


WuXi PharmaTech Selects Labcyte POD™ 810 Platform for High-Throughput Screening
December 07, 2009


Affymax Announces Close of Common Stock Offering and Exercise of Underwriters' Overallotment Option
November 24, 2009


WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump
November 17, 2009


NeuroStar TMS Therapy® Receives Prestigious Popular Science Award
November 12, 2009


3M Licenses Vaccine Adjuvants to VaxInnate
November 9, 2009


Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV
November 9, 2009


Transcept Pharmaceuticals Receives Notice of Allowance for U.S. Patent Application on Intermezzo®
November 4, 2009


Affymax and Takeda Announce Preliminary Phase 2 Data Demonstrated That Hematide™ Increased Hemoglobin in Dialysis Patients
October 30, 2009


Epocrates Celebrates 10 Years of Innovation
October 29, 2009


FDA Clears Interlace Medical’s MyoSure™ Hysteroscopic Tissue Removal System for The Treatment of Submucosal Fibroids
October 28th, 2009


Ligand to Acquire Metabasis for Cash and Contingent Value Rights
October 27, 2009


NxStage® Reports Significant Interim FREEDOM Study Results
October 27, 2009


Synageva Biopharma Announces Completion of $45 Million Financing with New $12 Million Investment, Addition of New Leaf Venture Partners to Investor Group, and Expansion of Senior Leadership Team
October 20, 2009


Prometheus Awarded Patent Related to Genetic Testing for Inflammatory Bowel Disease
October 20, 2009


WorldHeart Receives IRB Approval at First Center in the Levacor™ VAD BTT Clinical Trial Center On-Site Training Completed
October 15, 2009


Prometheus Launches ProOncDx Cancer Diagnostics
October 15, 2009


Relypsa Initiates Phase 2b Clinical Trial of RLY5016 for the Prevention of Hyperkalemia in Heart Failure Patients
October 7, 2009


Direct Flow Medical Presents Twelve Month Clinical Results with their Percutaneous Aortic Valve System at TCT
October 5, 2009


Boston Business Journal Names NxStage® Medical Third Fastest Growing Company in Massachusetts
October 1, 2009


Cyberonics Announces Epilepsy Technology Collaborations
October 1, 2009


Labcyte Signs Bioscreen Instruments as Exclusive Distributor in India
September 23, 2009


Intarcia Therapeutics, Inc. Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes
September 17, 2009


U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX™ for Dupuytren's Contracture
September 16, 2009


Concert Pharmaceuticals Presents Clinical Results Demonstrating Reduced Drug-Drug Interactions with a Deuterium-Modified Compound
September 14, 2009


NxStage® Announces Streamline® Blood Tubing Set Supply Agreement Between Medisystems® and Reliant Renal Care
September 14, 2009


Affymax Provides Phase 3 Program Update for Investigational Drug, Hematide™, to Treat Anemia in Chronic Renal Failure
September 9, 2009


Prometheus Announces Co-Pay Assistance Savings Program For LOTRONEX® (Alosteron Hcl) Tablets
September 9, 2009


ISTA Pharmaceuticals' Bepreve™ Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
September 8, 2009


ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
September 8, 2009


XIAFLEX™ CORD I Study Published in New England Journal of Medicine
September 2, 2009


Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
September 2, 2009


New Leaf Venture Partners Leads $30 Million Financing in Neuronetics
September 2, 2009


Tioga Pharmaceuticals, Inc. and Ono Pharmaceutical Co. Announce Agreement to Develop and Commercialize Asimadoline in Japan
September 1, 2009


Aureon Laboratories Announces Appointment of New CEO
August 25, 2009


ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom™ 0.09%
August 25, 2009


WorldHeart Receives US Clinical Study Approval for the Levacor™ VAD
August 20, 2009


Labcyte Awarded Second Japanese Patent
August 18, 2009


XDx Completes $14.4 Million Series G Financing XDx Poised to Achieve Break-Even in 2010
August 5, 2009


Auxilium Pharmaceuticals, Inc. Secures $30 Million Revolving Credit Line With Silicon Valley Bank
August 5, 2009


Dr. Nathaniel Brown Joins Presidio Pharmaceuticals, Inc. as Senior Vice President of Clinical Development
August 5, 2009


Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo® in the United States
August 2, 2009


U.S. Food and Drug Administration's Arthritis Advisory Committee Confirms Date to Review XIAFLEX™ for the Treatment of Dupuytren's Contracture
July 31, 2009


Affymax Announces Data Monitoring Committee Review of Phase 3 Hematide Program
July 20, 2009


Presidio Pharmaceuticals Inc. Raises $27 Million in Additional Financing
July 9, 2009


Presidio Pharmaceuticals, Inc. selects PPI-461 as a Clinical Candidate in their Hepatitis C Virus NS5A Program
July 7, 2009


Prometheus Launches MyCeliacID™, The First Do It Yourself, Saliva-Based Genetic Test Dedicated To Celiac Disease
June 29, 2009


U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX™ for the Treatment of Dupuytren's Contracture
June 18, 2009


Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo®
June 11, 2009


Metabasis Therapeutics Announces That Its Collaborator Merck & Co., Inc. Has Selected a Lead AMPK Activator for Late Preclinical Development and Has Agreed to Make a One-Time Payment for All Remaining Financial Obligations
June 10, 2009


Metabasis Therapeutics Receives a Development Event Payment from Roche and Notification That Roche Plans to Advance MB11362 into Development for the Treatment of Hepatitis C
June 5, 2009


Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs
June 2, 2009


Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
June 2, 2009


NxStage Extends Supply Agreement with B. Braun Medical Inc. to Include Streamline(R) Technology
June 1, 2009


Affymax® Reports Phase 2 Clinical Trial Data Supporting Hemoglobin Increases with Once-Per-Month Hematide™ Regardless of Patient Baseline Renal Function
May 26, 2009


Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
May 21, 2009


NxStage Announces Strategic Business Alliance with Asahi Kasei Kuraray Medical
May 18, 2009


VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round
May 6, 2009


XIAFLEX™ for the Treatment of Dupuytren's Contracture Receives Priority Review from the U.S. Food and Drug Administration
April 28, 2009


Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
April 13, 2009


Prometheus Highlights Record Performance in 2008
March 24, 2009


NxStage Announces Credit Facility Amendment
March 16, 2009


Prometheus Receives New York State Approval for Prometheus® IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome
March 16, 2009


Auxilium Submits Biologics License Application for XIAFLEX™ for the Treatment of Dupuytren's Contracture to the U.S. Food and Drug Administration
March 02, 2009


IlluminOss Medical Receives ISO 13485 Certification
February 20, 2009


IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology
February 19, 2009


Affymax Announces $42 Million Private Placement
February 17, 2009


Auxilium Pharmaceuticals, Inc. Completes Enrollment in Phase IIb Clinical Trial of XIAFLEX™ in Peyronie's Disease
February 2, 2009


Novacea Stockholders Approve Merger With Transcept
January 27, 2009


ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
January 22, 2009


WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor™ VAD
January 8, 2009